Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges
Shimin Xie, Zhengguo Wu, Yi Qi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111450-111450
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies
Cheng Wang, Shu Guang Dai, Xingtao Zhao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114882-114882
Open Access | Times Cited: 50
Lung cancer associated with combustion particles and fine particulate matter (PM2.5) - The roles of polycyclic aromatic hydrocarbons (PAHs) and the aryl hydrocarbon receptor (AhR)
Jørn A. Holme, Jan Vondráček, Miroslav Machala, et al.
Biochemical Pharmacology (2023) Vol. 216, pp. 115801-115801
Open Access | Times Cited: 43
Molecular mechanism of genetic, epigenetic, and metabolic alteration in lung cancer
Shahab Fatima, Vineet Kumar, Dhruv Kumar
Medical Oncology (2025) Vol. 42, Iss. 3
Closed Access | Times Cited: 2
Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer
Wei Zhang, Chunai Gong, Kai Chen, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 60
Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence
Jin Zhang, Yue Ma
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116909-116909
Open Access | Times Cited: 9
Synthesis and In Vitro Antitumor Activity Evaluation of Gefitinib-1,2,3-Triazole Derivatives
Zijun Liu, Jiancheng Liu, Gao En, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 837-837
Open Access | Times Cited: 8
The multi-molecular mechanisms of tumor-targeted drug resistance in precision medicine
Xinming Li, Mingdong Li, Meiying Huang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113064-113064
Open Access | Times Cited: 32
A comprehensive review on pharmacological, toxicity, and pharmacokinetic properties of phillygenin: Current landscape and future perspectives
Cheng Wang, Rui Wu, Shenglin Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115410-115410
Open Access | Times Cited: 19
Development and application of oncolytic viruses as the nemesis of tumor cells
Xiao Zhu, Chenyang Fan, Zhuolong Xiong, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 18
Global respiratory health priorities at the beginning of the 21st century
Catherine M. Greene, Mohamed Abdulkadir
European Respiratory Review (2024) Vol. 33, Iss. 172, pp. 230205-230205
Open Access | Times Cited: 6
Multi-Target Potential of Berberine as an Antineoplastic and Antimetastatic Agent: A Special Focus on Lung Cancer Treatment
Ijeoma Theresa Achi, Paromita Sarbadhikary, Blassan P. George, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3433-3433
Open Access | Times Cited: 27
Genomic instability drives tumorigenesis and metastasis and its implications for cancer therapy
Shihui Guo, Xiao Zhu, Ziyuan Huang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114036-114036
Open Access | Times Cited: 23
In-Depth Metaproteomics Analysis of Oral Microbiome for Lung Cancer
Xiaoteng Jiang, Yan Zhang, Huiyu Wang, et al.
Research (2022) Vol. 2022
Open Access | Times Cited: 22
Comparative proteomic profiling of plasma exosomes in lung cancer cases of liver and brain metastasis
Sini Li, Yan Qu, Lihui Liu, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Tanshinone IIA inhibits proliferation and migration by downregulation of the PI3K/Akt pathway in small cell lung cancer cells
Yuxin Jiang, Yanli Bi, Lingjie Zhou, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Non-Coding RNA as a Biomarker in Lung Cancer
C. Raman Suri, Shashikant Swarnkar, L.V.K.S. Bhaskar, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 5, pp. 50-50
Open Access | Times Cited: 4
Examination of the Association Between Bisphenol‐Related Genes and Lung Cancer
Lin Chen, Min Zhou, Dingliang Lv, et al.
Journal of Clinical Pharmacy and Therapeutics (2025) Vol. 2025, Iss. 1
Open Access
miR-224 activates cancer-associated fibroblasts to enhance lung cancer cell migration and invasion by targeting Akirin1
Seonyeong Oh, Sieun Lee, Inyoung Cheon, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Theoretical perspectives and clinical applications of non-coding RNA in lung cancer metastasis: a systematic review
Jie Yang, Yixin Luo, Zuhuan Yao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Exosomal lncRNA Mir100hg from lung cancer stem cells activates H3K14 lactylation to enhance metastatic activity in non-stem lung cancer cells
Lei Shi, Bowen Li, Jiyu Tan, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Metallothionein 2A enhances the yes-associated protein 1 signaling pathway to promote small-cell lung cancer metastasis
Hong Wu, Yangyang Gu, Lidong Xu
CytoJournal (2025) Vol. 22, pp. 25-25
Open Access
Targeting MAPK Signaling: Loureirins A and B from Dracaena Loureiri Inhibit Epithelial–Mesenchymal Transition and Invasion in Non-Small Cell Lung Cancer Cell Lines
Xiaomin Huang, Punnida Arjsri, Kamonwan Srisawad, et al.
Life (2025) Vol. 15, Iss. 3, pp. 396-396
Open Access
Inhalable pH-responsive core-shell nanocarriers with PEGylated chitosan/alginate layer-by-layer coating for sequential drug release in lung cancer therapy
Mariam Hossam Eldin, Reem K. Arafa, Osman Gamal, et al.
International Journal of Biological Macromolecules (2025), pp. 141851-141851
Closed Access
HNRNPC promotes progression of non-small cell lung cancer by maintaining TFAP2A mRNA stability
Minghua Liao, Chunyu Li, Rui Yang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Texasin, A main product from Caragana Jubata (Pall.) Poir, induces proliferation arrest and protective autophagy in lung adenocarcinoma
Liuzhao Cao, Tiantian Li, Xingxiang Xu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top